Consumer genetics company 23andMe announced Friday it has signed a definitive agreement to acquire telehealth and online prescription platform Lemonaid Health for $400 million.
The price tag, subject to downward adjustments, will be made up of 25% in cash and 75% in stock. The companies expect the acquisition to close by the end of the year.
“We believe that by combining Lemonaid Health’s...
Lemonaid Health, a San Francisco-based telehealth platform and provider, announced today $33 million in Series B funding. The new round was led by Olive Tree Ventures, and included Artis Ventures, Correlation Ventures, Hikma Ventures, Sierra Ventures and other unnamed backers. This latest round brings the company's fundraising total to $55 million.
Lemonaid said it will be using the new funds to...
Icebreaker Health, a relatively new telemedicine startup that raised $6.6 million in August, has expanded its Lemonaid app-based telehealth service into Michigan and New York (not to be confused with fitness tracking startup Lemonade Labs). Icebreaker Health already serves patients in Pennsylvania and California. The company's Chief Medical Officers is Dr. Jason Hwang, who co-authored The...
